'Heart damage due to anti-cancer drugs side effects' Suggest effective treatment
Nov 14, 2024
Medical staff at Hwasun Chonnam National University Hospital have discovered effective treatment and prevention methods for heart damage caused by side effects of anticancer drugs used to treat cancer.
Recently, a team of professors Hyukjin Park and Inuri of the Department of Circulatory Medicine published a paper 'Results of discontinuation of cardiac drug treatment in patients who recovered from anticancer heart toxicity in the American Heart Association Cardiology (JACC: Cardiooncology, IF=12.6), which is recognized as the highest authority in the field of cardiac oncology.
The paper found for the first time in the world that hospitalization or re-degradation of heart function due to heart failure can be effectively prevented only when heart toxicity caused by anticancer drugs is maintained continuously after smooth treatment.
In addition, a paper on the topic of 'Danger and Reversibility of Cardiac Toxicity Related to Osimertinib in Real Lung Cancer Patients' Official Journal of the International Association of Lung Cancer Research (IF=16.5), which has world-renowned authority in the field of lung cancer through multicenter research in Korea, is also evaluated as providing important information on cardiovascular toxicity and providing guidelines to doctors.
The paper shows that 'Oximertinib', an anticancer drug used in non-small cell lung cancer, causes heart-related side effects at a higher frequency than known in previous studies, but most can recover with proper circulatory coordination.
Professor Hyukjin Park said, "After cancer treatment, we will continue to conduct medical treatment and research activities to protect the cardiovascular health of patients." he said.
Recently, a team of professors Hyukjin Park and Inuri of the Department of Circulatory Medicine published a paper 'Results of discontinuation of cardiac drug treatment in patients who recovered from anticancer heart toxicity in the American Heart Association Cardiology (JACC: Cardiooncology, IF=12.6), which is recognized as the highest authority in the field of cardiac oncology.
The paper found for the first time in the world that hospitalization or re-degradation of heart function due to heart failure can be effectively prevented only when heart toxicity caused by anticancer drugs is maintained continuously after smooth treatment.
In addition, a paper on the topic of 'Danger and Reversibility of Cardiac Toxicity Related to Osimertinib in Real Lung Cancer Patients' Official Journal of the International Association of Lung Cancer Research (IF=16.5), which has world-renowned authority in the field of lung cancer through multicenter research in Korea, is also evaluated as providing important information on cardiovascular toxicity and providing guidelines to doctors.
The paper shows that 'Oximertinib', an anticancer drug used in non-small cell lung cancer, causes heart-related side effects at a higher frequency than known in previous studies, but most can recover with proper circulatory coordination.
Professor Hyukjin Park said, "After cancer treatment, we will continue to conduct medical treatment and research activities to protect the cardiovascular health of patients." he said.
|
bellho@sportschosun.com
